VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
FDA premarket approval P020011/S004 · decided 2010-09-17
Approval details
- PMA number
- P020011
- Supplement
- S004
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Applicant
- Gen-Probe
- Date received
- 2010-08-23
- Decision date
- 2010-09-17
- Days to decision
- 25 days
- Decision code
- OK30
- Product code
- MZP
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- MODIFICATION TO THE PURIFICATION AND DESALTING PROCESSES FOR TWO CLASSES OF OLIGONUCLEOTIDES (RXL INTERMEDIATES AND PPOS), WHICH ARE COMPONENTS OF SOME REAGENTS OF THE DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.